Q3FY17 Results : Sun Pharamceutical Industries Ltd
Bhagyashree Vivarekar / 14 Feb 2017
The company reported PAT of Rs 1471.82 crore, which represents a sequential QoQ decline of 34.15 per cent and a YoY decline of 4.73 per cent.
Sun Pharmaceutical Ltd. reported its results for the quarter ended December 31, 2016.
The company's total sales for Q3FY17 were Rs 7912.66 crore, which represents a 4.09 per cent sequential decline and 11.1 per cent YoY increase.
Its operating profit (EBIT) for the quarter came in at Rs 2146.33 crore, with EBIT margin of 27.13 per cent.
The company reported PAT of Rs 1471.82 crore, which represents a sequential QoQ decline of 34.15 per cent and a YoY decline of 4.73 per cent.
The company's stock opened at Rs 650.15 on the BSE, and fell 1.19 per cent after the results were declared. It is currently trading around Rs 650.15.
Sun Pharamceutical Industries Ltd is a speciality pharma company.The company's brands are mainly prescribed for chronic therapeutic areas like cardiology, psychiatry, neurology, gastroenterology, diabetology, ophthalmology, orthopaedics, etc. The company operates in only one segment - pharmaceuticals.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.